Loading…

Bayesian validation framework for dynamic epidemic models

Complex models of infectious diseases are used to understand the transmission dynamics of the disease, project the course of an epidemic, predict the effect of interventions and/or provide information for power calculations of community level intervention studies. However, there have been relatively...

Full description

Saved in:
Bibliographic Details
Published in:Epidemics 2021-12, Vol.37, p.100514-100514, Article 100514
Main Authors: Dasgupta, Sayan, Moore, Mia R., Dimitrov, Dobromir T., Hughes, James P.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c529t-d8cd8ce226c33fd7926b8e2c3a276ae518d7695cb38788640f8522d8901d030e3
cites cdi_FETCH-LOGICAL-c529t-d8cd8ce226c33fd7926b8e2c3a276ae518d7695cb38788640f8522d8901d030e3
container_end_page 100514
container_issue
container_start_page 100514
container_title Epidemics
container_volume 37
creator Dasgupta, Sayan
Moore, Mia R.
Dimitrov, Dobromir T.
Hughes, James P.
description Complex models of infectious diseases are used to understand the transmission dynamics of the disease, project the course of an epidemic, predict the effect of interventions and/or provide information for power calculations of community level intervention studies. However, there have been relatively few opportunities to rigorously evaluate the predictions of such models till now. Indeed, while there is a large literature on calibration (fitting model parameters) and validation (comparing model outputs to data) of complex models based on empirical data, the lack of uniformity in accepted criteria for such procedures for models of infectious diseases has led to simple procedures being prevalent for such steps. However, recently, several community level randomized trials of combination HIV intervention have been planned and/or initiated, and in each case, significant epidemic modeling efforts were conducted during trial planning which were integral to the design of these trials. The existence of these models and the (anticipated) availability of results from the related trials, provide a unique opportunity to evaluate the models and their usefulness in trial design. In this project, we outline a framework for evaluating the predictions of complex epidemiological models and describe experiments that can be used to test their predictions. •Framework for evaluating predictions of epidemiological models (e.g., HIV transmission models).•Evaluating posterior distribution of the model discrepancy using a Bayesian framework.•Allowing for re-calibration of parameters by updating their priors in a MCMC analysis.•Identifying communities where the model fails by providing a goodness of fit evaluation using posterior tail probability.
doi_str_mv 10.1016/j.epidem.2021.100514
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_f1ade0d3f22e476e9f1303a98b830ced</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S175543652100061X</els_id><doaj_id>oai_doaj_org_article_f1ade0d3f22e476e9f1303a98b830ced</doaj_id><sourcerecordid>2597488445</sourcerecordid><originalsourceid>FETCH-LOGICAL-c529t-d8cd8ce226c33fd7926b8e2c3a276ae518d7695cb38788640f8522d8901d030e3</originalsourceid><addsrcrecordid>eNp9UctOHDEQtKKg8MofRGiOuczitz0XpAQFgoSUC5wtr90mXmbGiz27aP8-hiEELpEsuVXdXdXdhdAXghcEE3m6WsA6ehgWFFNSISwI_4AOiFa6xViqjzVWQrScSbGPDktZVZQTwj6hfcaVZESSA9R9tzso0Y7N1vbR2ymmsQnZDvCY8n0TUm78brRDdM0sV4MheejLMdoLti_w-eU_QrcXP27Of7bXvy6vzr9dt07Qbmq9dvUBpdIxFrzqqFxqoI5ZqqQFQbRXshNuyergWnIctKDU6w4TjxkGdoSuZl6f7Mqscxxs3plko3kGUr4zNk_R9WACsR6wZ4FSqBtCFwjDzHZ6qRl24CvX2cy13iwH8A7GKdv-Hen7zBh_m7u0NVrVK0tWCb6-EOT0sIEymSEWB31vR0ibYqjoFNeac1FL-VzqciolQ3iVIdg8OWhWZj6peXLQzA7WtpO3I742_bXs3w7VA9hGyKa4CGNdL2ZwU71K_L_CH05HrnA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2597488445</pqid></control><display><type>article</type><title>Bayesian validation framework for dynamic epidemic models</title><source>Elsevier ScienceDirect Journals</source><creator>Dasgupta, Sayan ; Moore, Mia R. ; Dimitrov, Dobromir T. ; Hughes, James P.</creator><creatorcontrib>Dasgupta, Sayan ; Moore, Mia R. ; Dimitrov, Dobromir T. ; Hughes, James P.</creatorcontrib><description>Complex models of infectious diseases are used to understand the transmission dynamics of the disease, project the course of an epidemic, predict the effect of interventions and/or provide information for power calculations of community level intervention studies. However, there have been relatively few opportunities to rigorously evaluate the predictions of such models till now. Indeed, while there is a large literature on calibration (fitting model parameters) and validation (comparing model outputs to data) of complex models based on empirical data, the lack of uniformity in accepted criteria for such procedures for models of infectious diseases has led to simple procedures being prevalent for such steps. However, recently, several community level randomized trials of combination HIV intervention have been planned and/or initiated, and in each case, significant epidemic modeling efforts were conducted during trial planning which were integral to the design of these trials. The existence of these models and the (anticipated) availability of results from the related trials, provide a unique opportunity to evaluate the models and their usefulness in trial design. In this project, we outline a framework for evaluating the predictions of complex epidemiological models and describe experiments that can be used to test their predictions. •Framework for evaluating predictions of epidemiological models (e.g., HIV transmission models).•Evaluating posterior distribution of the model discrepancy using a Bayesian framework.•Allowing for re-calibration of parameters by updating their priors in a MCMC analysis.•Identifying communities where the model fails by providing a goodness of fit evaluation using posterior tail probability.</description><identifier>ISSN: 1755-4365</identifier><identifier>EISSN: 1878-0067</identifier><identifier>DOI: 10.1016/j.epidem.2021.100514</identifier><identifier>PMID: 34763161</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Bayes Theorem ; Bayesian credible interval ; Communicable Diseases - epidemiology ; Epidemics ; Epidemiological model validation ; HIV transmission model ; Humans ; Markov Chain Monte Carlo</subject><ispartof>Epidemics, 2021-12, Vol.37, p.100514-100514, Article 100514</ispartof><rights>2021 The Authors</rights><rights>Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c529t-d8cd8ce226c33fd7926b8e2c3a276ae518d7695cb38788640f8522d8901d030e3</citedby><cites>FETCH-LOGICAL-c529t-d8cd8ce226c33fd7926b8e2c3a276ae518d7695cb38788640f8522d8901d030e3</cites><orcidid>0000-0001-5055-7075 ; 0000-0001-5271-7247</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S175543652100061X$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,3549,27924,27925,45780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34763161$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dasgupta, Sayan</creatorcontrib><creatorcontrib>Moore, Mia R.</creatorcontrib><creatorcontrib>Dimitrov, Dobromir T.</creatorcontrib><creatorcontrib>Hughes, James P.</creatorcontrib><title>Bayesian validation framework for dynamic epidemic models</title><title>Epidemics</title><addtitle>Epidemics</addtitle><description>Complex models of infectious diseases are used to understand the transmission dynamics of the disease, project the course of an epidemic, predict the effect of interventions and/or provide information for power calculations of community level intervention studies. However, there have been relatively few opportunities to rigorously evaluate the predictions of such models till now. Indeed, while there is a large literature on calibration (fitting model parameters) and validation (comparing model outputs to data) of complex models based on empirical data, the lack of uniformity in accepted criteria for such procedures for models of infectious diseases has led to simple procedures being prevalent for such steps. However, recently, several community level randomized trials of combination HIV intervention have been planned and/or initiated, and in each case, significant epidemic modeling efforts were conducted during trial planning which were integral to the design of these trials. The existence of these models and the (anticipated) availability of results from the related trials, provide a unique opportunity to evaluate the models and their usefulness in trial design. In this project, we outline a framework for evaluating the predictions of complex epidemiological models and describe experiments that can be used to test their predictions. •Framework for evaluating predictions of epidemiological models (e.g., HIV transmission models).•Evaluating posterior distribution of the model discrepancy using a Bayesian framework.•Allowing for re-calibration of parameters by updating their priors in a MCMC analysis.•Identifying communities where the model fails by providing a goodness of fit evaluation using posterior tail probability.</description><subject>Bayes Theorem</subject><subject>Bayesian credible interval</subject><subject>Communicable Diseases - epidemiology</subject><subject>Epidemics</subject><subject>Epidemiological model validation</subject><subject>HIV transmission model</subject><subject>Humans</subject><subject>Markov Chain Monte Carlo</subject><issn>1755-4365</issn><issn>1878-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9UctOHDEQtKKg8MofRGiOuczitz0XpAQFgoSUC5wtr90mXmbGiz27aP8-hiEELpEsuVXdXdXdhdAXghcEE3m6WsA6ehgWFFNSISwI_4AOiFa6xViqjzVWQrScSbGPDktZVZQTwj6hfcaVZESSA9R9tzso0Y7N1vbR2ymmsQnZDvCY8n0TUm78brRDdM0sV4MheejLMdoLti_w-eU_QrcXP27Of7bXvy6vzr9dt07Qbmq9dvUBpdIxFrzqqFxqoI5ZqqQFQbRXshNuyergWnIctKDU6w4TjxkGdoSuZl6f7Mqscxxs3plko3kGUr4zNk_R9WACsR6wZ4FSqBtCFwjDzHZ6qRl24CvX2cy13iwH8A7GKdv-Hen7zBh_m7u0NVrVK0tWCb6-EOT0sIEymSEWB31vR0ibYqjoFNeac1FL-VzqciolQ3iVIdg8OWhWZj6peXLQzA7WtpO3I742_bXs3w7VA9hGyKa4CGNdL2ZwU71K_L_CH05HrnA</recordid><startdate>20211201</startdate><enddate>20211201</enddate><creator>Dasgupta, Sayan</creator><creator>Moore, Mia R.</creator><creator>Dimitrov, Dobromir T.</creator><creator>Hughes, James P.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-5055-7075</orcidid><orcidid>https://orcid.org/0000-0001-5271-7247</orcidid></search><sort><creationdate>20211201</creationdate><title>Bayesian validation framework for dynamic epidemic models</title><author>Dasgupta, Sayan ; Moore, Mia R. ; Dimitrov, Dobromir T. ; Hughes, James P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c529t-d8cd8ce226c33fd7926b8e2c3a276ae518d7695cb38788640f8522d8901d030e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Bayes Theorem</topic><topic>Bayesian credible interval</topic><topic>Communicable Diseases - epidemiology</topic><topic>Epidemics</topic><topic>Epidemiological model validation</topic><topic>HIV transmission model</topic><topic>Humans</topic><topic>Markov Chain Monte Carlo</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dasgupta, Sayan</creatorcontrib><creatorcontrib>Moore, Mia R.</creatorcontrib><creatorcontrib>Dimitrov, Dobromir T.</creatorcontrib><creatorcontrib>Hughes, James P.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Epidemics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dasgupta, Sayan</au><au>Moore, Mia R.</au><au>Dimitrov, Dobromir T.</au><au>Hughes, James P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bayesian validation framework for dynamic epidemic models</atitle><jtitle>Epidemics</jtitle><addtitle>Epidemics</addtitle><date>2021-12-01</date><risdate>2021</risdate><volume>37</volume><spage>100514</spage><epage>100514</epage><pages>100514-100514</pages><artnum>100514</artnum><issn>1755-4365</issn><eissn>1878-0067</eissn><abstract>Complex models of infectious diseases are used to understand the transmission dynamics of the disease, project the course of an epidemic, predict the effect of interventions and/or provide information for power calculations of community level intervention studies. However, there have been relatively few opportunities to rigorously evaluate the predictions of such models till now. Indeed, while there is a large literature on calibration (fitting model parameters) and validation (comparing model outputs to data) of complex models based on empirical data, the lack of uniformity in accepted criteria for such procedures for models of infectious diseases has led to simple procedures being prevalent for such steps. However, recently, several community level randomized trials of combination HIV intervention have been planned and/or initiated, and in each case, significant epidemic modeling efforts were conducted during trial planning which were integral to the design of these trials. The existence of these models and the (anticipated) availability of results from the related trials, provide a unique opportunity to evaluate the models and their usefulness in trial design. In this project, we outline a framework for evaluating the predictions of complex epidemiological models and describe experiments that can be used to test their predictions. •Framework for evaluating predictions of epidemiological models (e.g., HIV transmission models).•Evaluating posterior distribution of the model discrepancy using a Bayesian framework.•Allowing for re-calibration of parameters by updating their priors in a MCMC analysis.•Identifying communities where the model fails by providing a goodness of fit evaluation using posterior tail probability.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>34763161</pmid><doi>10.1016/j.epidem.2021.100514</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-5055-7075</orcidid><orcidid>https://orcid.org/0000-0001-5271-7247</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1755-4365
ispartof Epidemics, 2021-12, Vol.37, p.100514-100514, Article 100514
issn 1755-4365
1878-0067
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_f1ade0d3f22e476e9f1303a98b830ced
source Elsevier ScienceDirect Journals
subjects Bayes Theorem
Bayesian credible interval
Communicable Diseases - epidemiology
Epidemics
Epidemiological model validation
HIV transmission model
Humans
Markov Chain Monte Carlo
title Bayesian validation framework for dynamic epidemic models
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T14%3A26%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bayesian%20validation%20framework%20for%20dynamic%20epidemic%20models&rft.jtitle=Epidemics&rft.au=Dasgupta,%20Sayan&rft.date=2021-12-01&rft.volume=37&rft.spage=100514&rft.epage=100514&rft.pages=100514-100514&rft.artnum=100514&rft.issn=1755-4365&rft.eissn=1878-0067&rft_id=info:doi/10.1016/j.epidem.2021.100514&rft_dat=%3Cproquest_doaj_%3E2597488445%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c529t-d8cd8ce226c33fd7926b8e2c3a276ae518d7695cb38788640f8522d8901d030e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2597488445&rft_id=info:pmid/34763161&rfr_iscdi=true